Image credit- pharmaintelligence.com
The Northern Health Science Alliance (NHSA) in the UK has signed a memorandum of understanding (MoU) with Singapore-based firm Zicom MedTacc to boost the growth of the medtech sector in Northern England.
Under the terms of the strategic partnership, Singaporean medtech companies will go to Northern England for the development and internationalisation of new medical technology.
These companies will be able to carry out British clinical validation and evaluate economic impact through the NHSA, while the Northern region will have access to new technologies and treatments.
The deal will aid Northern medtech diagnostic and digital health companies to launch their products in Asia Pacific countries through NHSA’s strategic partners in Singapore.
Through the deal, NHSA also intends to support high-skilled jobs and investment in the region over long-term.
